Japan has granted fast-track approval to U.S. drug maker Pfizer Inc.’s COVID-19 pill, the heath minister said Thursday, as the country struggles to slow fast-spreading omicron infections.
The approval came less than a month after Pfizer applied in mid-January, an exceptional speed in a country where foreign drug approvals usually take much longer.
